Genito-Urinary Drugs Global Market Report 2022

Genito-Urinary Drugs Global Market Report 2022 – By Type (Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Name: Genito-Urinary Drugs Global Market Report 2022
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Genito-Urinary Drugs Global Market Report 2022

Starting Price : $5000.00 $4000.00 | Pages : 300 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities (organizations, sole traders and partnerships) that produce genito-urinary drugs to treat genito- urinary diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. This industry includes establishments that produce infertility drugs, hormonal contraceptives, erectile dysfunction drugs and hormonal replacement drugs to treat infertility, infections and prevent pregnancy. It also consists of establishments which produce drugs for benign prostatic hypertrophy, drugs for urinary incontinence and overactive bladder, diuretics to treat urinary calculi, glomerular disorders and other urinary disorders.

The main types of genito-urinary drugs are hormonal contraceptives, drugs for benign prostatic hypertrophy, drugs for infertility, drugs for erectile dysfunction, drugs for urinary incontinence and overactive bladder, drugs for infections and others, drugs for hormonal replacement therapy and diuretics. Hormonal contraceptives are medications or devices that reduce the likelihood of becoming pregnant. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

The global genito-urinary drugs market size is expected to grow from $40.40 billion in 2021 to $42.75 billion in 2022 at a compound annual growth rate (CAGR) of 5.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The genito-urinary drugs market is expected to reach $63.83 billion in 2026 at a CAGR of 10.5%.

The aging population profile of most countries contributed to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally, contributed significantly to the growth of the market during the historic period. According to the WHO, by 2030, one in every six people on the planet will be 60 or older. The proportion of the population aged 60 and up will rise from 1 billion in 2020 to 2.2 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. This has led to increased demand for pharmaceuticals products, significantly impacting market growth during this period.

Regulatory agencies and federal governments adopted stringent regulations and took a tough stance on drug pricing by pharmaceutical companies during the historic period. Pharmaceutical companies faced criticism from politicians, patients and physicians over high pricing of some medicines and drugs. Moreover, companies had to sell drugs and medicines at subsidized rates to government hospitals, doctors and clinics, further effecting companies’ revenues. This led to drug manufacturing companies operating on a reduced profit margin, which negatively impacted the attractiveness of the genito-urinary drugs industry in the historic period.

Pharmaceutical companies are investing in development of new class drugs for treating overactive bladders (OAB). Earlier anti-muscarinic agents have been used for the treatment of OAB. Going forward, the market is expected to be driven by a new class of drug known as beta-3 adrenergic agonists that has been increasingly used to treat OAB. Beta-3 adrenergic agonists are drugs which cause the bladder muscles to relax without causing side effects such as dry mouth. For instance, In December 2019, GEMTESA's new drug application (NDA) was submitted to the US Food and Drug Administration (FDA), and it was accepted for review in March 2020. GEMTESA ® is a beta-3 adrenergic agonist used to treat overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Major companies in the genito-urinary drugs market include Sanofi S.A, GlaxosmithKline, AstraZeneca, AbbVie, Reckitt, Benckiser Group plc, Astellas Pharma Inc., Otsuka Holdings Co ltd, Pfizer Inc., Merck KGaA and Daiichi Sankyo Company.

North America was the largest region in the genito-urinary market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the genito-urinary drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dermatology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global genito-urinary drugs market is segmented -

1) By Type: Hormonal Contraceptives, Drugs for Benign Prostatic Hypertrophy, Drugs for Infertility, Drugs for Erectile Dysfunction, Drugs for Urinary Incontinence and Overactive Bladder, Drugs for Infections and Others, Drugs for Hormonal Replacement Therapy, Diuretics

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Book your 30 minutes free consultation with our research experts

1. Executive Summary

2. Report Structure

3. Genito-Urinary Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Genito-Urinary Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Genito-Urinary Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Genito-Urinary Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Genito-Urinary Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Genito-Urinary Drugs

9. Genito-Urinary Drugs Market Size And Growth

9.1. Market Size

9.2. Historic Market Growth, Value ($ Billion)

9.2.1. Drivers Of The Market

9.2.2. Restraints On The Market

9.3. Forecast Market Growth, Value ($ Billion)

9.3.1. Drivers Of The Market

9.3.2. Restraints On The Market

10. Genito-Urinary Drugs Market Regional Analysis

10.1. Global Genito-Urinary Drugs Market, 2021, By Region, Value ($ Billion)

10.2. Global Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

10.3. Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region

11. Genito-Urinary Drugs Market Segmentation

11.1. Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hormonal Contraceptives

Drugs For Benign Prostatic hypertrophy

Drugs For Infertility

Drugs For Erectile Dysfunction

Drugs For Urinary Incontinence And Overactive Bladder

Drugs For Infections And Others

Drugs For Hormonal Replacement Therapy

Diuretics

11.2. Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

11.3. Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Oral

Parenteral

Others

11.4. Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Branded Drugs

Generic Drugs

11.5. Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

12. Genito-Urinary Drugs Market Metrics

12.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, 2016-2026, Global

12.2. Per Capita Average Genito-Urinary Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Genito-Urinary Drugs Market

13.1. Asia-Pacific Genito-Urinary Drugs Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. Asia-Pacific, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

13.3. Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

13.4. Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

13.5. Asia-Pacific, Genito-Urinary Drugs Market Metrics

13.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Asia-Pacific Countries

13.6. Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis

13.7.1. China Genito-Urinary Drugs Market

13.7.1.1. China Genito-Urinary Drugs Market Overview

13.7.1.2. China Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.1.3. China Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2. Australia Genito-Urinary Drugs Market

13.7.2.1. Australia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2.2. Australia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.3. Hong Kong Genito-Urinary Drugs Market

13.7.3.1. Hong Kong Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4. India Genito-Urinary Drugs Market

13.7.4.1. India Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4.2. India Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5. Indonesia Genito-Urinary Drugs Market

13.7.5.1. Indonesia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5.2. Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6. Japan Genito-Urinary Drugs Market

13.7.6.1. Japan Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6.2. Japan Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.7. Malaysia Genito-Urinary Drugs Market

13.7.7.1. Malaysia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.8. New Zealand Genito-Urinary Drugs Market

13.7.8.1. New Zealand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.9. Philippines Genito-Urinary Drugs Market

13.7.9.1. Philippines Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.10. Singapore Genito-Urinary Drugs Market

13.7.10.1. Singapore Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11. South Korea Genito-Urinary Drugs Market

13.7.11.1. South Korea Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11.2. South Korea Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.12. Thailand Genito-Urinary Drugs Market

13.7.12.1. Thailand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.13. Vietnam Genito-Urinary Drugs Market

13.7.13.1. Vietnam Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Genito-Urinary Drugs Market

14.1. Western Europe Genito-Urinary Drugs Market Overview

14.2. Western Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

14.3. Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

14.4. Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

14.5. Western Europe, Genito-Urinary Drugs Market Metrics

14.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Western Europe Countries

14.6. Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7. Western Europe Genito-Urinary Drugs Market: Country Analysis

14.7.1. Austria Genito-Urinary Drugs Market

14.7.1.1. Austria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.2. Belgium Genito-Urinary Drugs Market

14.7.2.1. Belgium Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.3. Denmark Genito-Urinary Drugs Market

14.7.3.1. Denmark Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.4. Finland Genito-Urinary Drugs Market

14.7.4.1. Finland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5. France Genito-Urinary Drugs Market

14.7.5.1. France Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5.2. France Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6. Germany Genito-Urinary Drugs Market

14.7.6.1. Germany Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6.2. Germany Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.7. Ireland Genito-Urinary Drugs Market

14.7.7.1. Ireland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.8. Italy Genito-Urinary Drugs Market

14.7.8.1. Italy Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.9. Netherlands Genito-Urinary Drugs Market

14.7.9.1. Netherlands Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.10. Norway Genito-Urinary Drugs Market

14.7.10.1. Norway Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.11. Portugal Genito-Urinary Drugs Market

14.7.11.1. Portugal Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.12. Spain Genito-Urinary Drugs Market

14.7.12.1. Spain Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.13. Sweden Genito-Urinary Drugs Market

14.7.13.1. Sweden Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.14. Switzerland Genito-Urinary Drugs Market

14.7.14.1. Switzerland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15. UK Genito-Urinary Drugs Market

14.7.15.1. UK Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15.2. UK Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Genito-Urinary Drugs Market

15.1. Eastern Europe Genito-Urinary Drugs Market Overview

15.2. Eastern Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

15.3. Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

15.4. Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

15.5. Eastern Europe, Genito-Urinary Drugs Market Metrics

15.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Eastern Europe Countries

15.6. Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7. Eastern Europe Genito-Urinary Drugs Market: Country Analysis

15.7.1. Czech Republic Genito-Urinary Drugs Market,

15.7.1.1. Czech Republic Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.2. Poland Genito-Urinary Drugs Market

15.7.2.1. Poland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.3. Romania Genito-Urinary Drugs Market

15.7.3.1. Romania Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4. Russia Genito-Urinary Drugs Market

15.7.4.1. Russia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4.2. Russia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Genito-Urinary Drugs Market

16.1. North America Genito-Urinary Drugs Market Overview

16.2. North America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

16.3. North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

16.4. North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

16.5. North America, Genito-Urinary Drugs Market Metrics

16.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, North America Countries

16.6. North America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7. North America Genito-Urinary Drugs Market: Country Analysis

16.7.1. Canada Genito-Urinary Drugs Market

16.7.1.1. Canada Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.2. Mexico Genito-Urinary Drugs Market

16.7.2.1. Mexico Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3. USA Genito-Urinary Drugs Market

16.7.3.1. USA Genito-Urinary Drugs Market Overview

16.7.3.2. USA Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3.3. USA Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Genito-Urinary Drugs Market

17.1. South America Genito-Urinary Drugs Market Overview

17.2. South America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

17.3. South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

17.4. South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

17.5. South America, Genito-Urinary Drugs Market Metrics

17.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, South America Countries

17.6. South America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7. South America Genito-Urinary Drugs Market: Country Analysis

17.7.1. Argentina Genito-Urinary Drugs Market

17.7.1.1. Argentina Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2. Brazil Genito-Urinary Drugs Market

17.7.1.1. Brazil Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2.2. Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.3. Chile Genito-Urinary Drugs Market

17.7.3.1. Chile Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.4. Colombia Genito-Urinary Drugs Market

17.7.4.1. Colombia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.5. Peru Genito-Urinary Drugs Market

17.7.5.1. Peru Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.6. Venezuela Genito-Urinary Drugs Market

17.7.6.1. Venezuela Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Genito-Urinary Drugs Market

18.1. Middle East Genito-Urinary Drugs Market Overview

18.2. Middle East, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

18.3. Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

18.4. Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

18.5. Middle East, Genito-Urinary Drugs Market Metrics

18.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Middle East Countries

18.6. Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7. Middle East Genito-Urinary Drugs Market: Country Analysis

18.7.1. Saudi Arabia Genito-Urinary Drugs Market

18.7.1.1. Saudi Arabia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.2. Israel Genito-Urinary Drugs Market

18.7.2.1. Israel Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.3. Turkey Genito-Urinary Drugs Market

18.7.3.1. Turkey Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.4. UAE Genito-Urinary Drugs Market

18.7.4.1. UAE Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Genito-Urinary Drugs Market

19.1. Africa Genito-Urinary Drugs Market Overview

19.2. Africa, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

19.3. Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

19.4. Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

19.5. Africa, Genito-Urinary Drugs Market Metrics

19.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Africa Countries

19.6. Africa Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7. Africa Genito-Urinary Drugs Market: Country Analysis

19.7.1. Egypt Genito-Urinary Drugs Market

19.7.1.1. Egypt Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.2. Nigeria Genito-Urinary Drugs Market

19.7.2.1. Nigeria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.3. South Africa Genito-Urinary Drugs Market

19.7.3.1. South Africa Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Genito-Urinary Drugs Market Competitive Landscape

20.1. Competitive Market Overview

20.2. Market Shares

20.3. Company Profiles

20.3.1. Sanofi S.A

20.3.1.1. Company Overview

20.3.1.2. Products And Services

20.3.1.3. Strategy

20.3.1.4. Financial Performance

20.3.2. GlaxosmithKline

20.3.2.1. Company Overview

20.3.2.2. Products And Services

20.3.2.3. Strategy

20.3.2.4. Financial Performance

20.3.3. AstraZeneca

20.3.3.1. Company Overview

20.3.3.2. Products And Services

20.3.3.3. Strategy

20.3.3.4. Financial Performance

20.3.4. AbbVie

20.3.4.1. Company Overview

20.3.4.2. Products And Services

20.3.4.3. Strategy

20.3.4.4. Financial Performance

20.3.5. Reckitt

20.3.5.1. Company Overview

20.3.5.2. Products And Services

20.3.5.3. Strategy

20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market

22. Market Background: Pharmaceutical Drugs Market

22.1. Pharmaceutical Drugs Market Characteristics

22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

23.1. Global Genito-Urinary Drugs Market In 2026- Growth Countries

23.2. Global Genito-Urinary Drugs Market In 2026- Growth Segments

23.3. Global Genito-Urinary Drugs Market In 2026- Growth Strategies

24. Appendix

24.1. NAICS Definitions Of Industry Covered In This Report

24.2. Abbreviations

24.3. Currencies

24.4. Research Inquiries

24.5. The Business Research Company

25. Copyright And Disclaimer

List Of Tables

Table 1: Historic Market Growth, Value ($ Billion)

Table 2: Forecast Market Growth, Value ($ Billion)

Table 3: Global Genito-Urinary Drugs Market, 2021, By Region, Value ($ Billion)

Table 4: Global Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 5: Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 7: Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 8: Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 9: Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 10: Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 11: Genito-Urinary Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Table 12: Per Capita Average Genito-Urinary Drugs Market Expenditure, 2016-2026, Global

Table 13: Asia-Pacific, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 14: Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 15: Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 16: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Table 17: Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 18: China Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 19: China Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 20: Australia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 21: Australia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 22: Hong Kong Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 23: India Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 24: India Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 25: Indonesia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 26: Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 27: Japan Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 28: Japan Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 29: Malaysia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 30: New Zealand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 31: Philippines Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 32: Singapore Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 33: South Korea Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 34: Thailand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 35: Vietnam Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 36: Western Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 37: Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 38: Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 39: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Western Europe Countries

Table 40: Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 41: Austria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 42: Belgium Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 43: Denmark Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 44: Finland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 45: France Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 46: France Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 47: Germany Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 48: Germany Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 49: Ireland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 50: Italy Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 51: Netherlands Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 52: Norway Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 53: Portugal Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 54: Spain Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 55: Sweden Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 56: Switzerland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 57: UK Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 58: UK Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 59: Eastern Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 60: Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 61: Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 62: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Eastern Europe Countries

Table 63: Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 64: Czech Republic Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 65: Poland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 66: Romania Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 67: Russia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 68: Russia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 69: North America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 70: North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 71: North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 72: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, North America Countries

Table 73: North America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 74: Canada Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 75: Mexico Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 76: USA Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 77: USA Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 78: South America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 79: South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 80: South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 81: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, South America Countries

Table 82: South America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 83: Argentina Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 84: Brazil Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 85: Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 86: Chile Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 87: Colombia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 88: Peru Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 89: Venezuela Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 90: Middle East, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 91: Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 92: Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 93: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Middle East Countries

Table 94: Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 95: Saudi Arabia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 96: Israel Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 97: Turkey Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 98: UAE Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 99: Africa, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Table 100: Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 101: Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 102: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Africa Countries

Table 103: Africa Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 104: Egypt Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 105: Nigeria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 106: South Africa Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 107: Sanofi S.A Financial Performance

Table 108: GlaxosmithKline Financial Performance

Table 109: AstraZeneca Financial Performance

Table 110: AbbVie Financial Performance

Table 111: Reckitt Financial Performance

Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Table 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Table 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Table 116: Global Genito-Urinary Drugs Market In 2026- Growth Countries

Table 117: Global Genito-Urinary Drugs Market In 2026- Growth Segments

Table 118: Global Genito-Urinary Drugs Market In 2026- Growth Strategies

List Of Figures

Figure 1: Historic Market Growth, Value ($ Billion)

Figure 2: Forecast Market Growth, Value ($ Billion)

Figure 3: Global Genito-Urinary Drugs Market, 2021, By Region, Value ($ Billion)

Figure 4: Global Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 5: Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 7: Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 8: Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 9: Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 10: Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 11: Genito-Urinary Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Figure 12: Per Capita Average Genito-Urinary Drugs Market Expenditure, 2016-2026, Global

Figure 13: Asia-Pacific, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 14: Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 15: Asia-Pacific, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 16: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Figure 17: Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 18: China Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 19: China Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 20: Australia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 21: Australia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 22: Hong Kong Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 23: India Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 24: India Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 25: Indonesia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 26: Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 27: Japan Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 28: Japan Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 29: Malaysia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 30: New Zealand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 31: Philippines Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 32: Singapore Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 33: South Korea Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 34: Thailand Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 35: Vietnam Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 36: Western Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 37: Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 38: Western Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 39: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Western Europe Countries

Figure 40: Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 41: Austria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 42: Belgium Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 43: Denmark Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 44: Finland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 45: France Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 46: France Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 47: Germany Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 48: Germany Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 49: Ireland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 50: Italy Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 51: Netherlands Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 52: Norway Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 53: Portugal Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 54: Spain Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 55: Sweden Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 56: Switzerland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 57: UK Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 58: UK Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 59: Eastern Europe, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 60: Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 61: Eastern Europe, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 62: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Eastern Europe Countries

Figure 63: Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 64: Czech Republic Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 65: Poland Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 66: Romania Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 67: Russia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 68: Russia Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 69: North America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 70: North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 71: North America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 72: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, North America Countries

Figure 73: North America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 74: Canada Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 75: Mexico Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 76: USA Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 77: USA Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 78: South America, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 79: South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 80: South America, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 81: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, South America Countries

Figure 82: South America Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 83: Argentina Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 84: Brazil Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 85: Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 86: Chile Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 87: Colombia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 88: Peru Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 89: Venezuela Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 90: Middle East, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 91: Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 92: Middle East, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 93: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Middle East Countries

Figure 94: Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 95: Saudi Arabia Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 96: Israel Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 97: Turkey Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 98: UAE Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 99: Africa, Genito-Urinary Drugs Market, 2021, By Country, Value ($ Billion)

Figure 100: Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 101: Africa, Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 102: Per Capita Average Genito-Urinary Drugs Expenditure, 2016-2026, Africa Countries

Figure 103: Africa Genito-Urinary Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 104: Egypt Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 105: Nigeria Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 106: South Africa Genito-Urinary Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 107: Sanofi S.A Financial Performance

Figure 108: GlaxosmithKline Financial Performance

Figure 109: AstraZeneca Financial Performance

Figure 110: AbbVie Financial Performance

Figure 111: Reckitt Financial Performance

Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Figure 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Figure 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Figure 116: Global Genito-Urinary Drugs Market In 2026- Growth Countries

Figure 117: Global Genito-Urinary Drugs Market In 2026- Growth Segments

Figure 118: Global Genito-Urinary Drugs Market In 2026- Growth Strategies

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the antivirals market research report 2022 with industry size, share, segments and market growth

Drugs For Benign Prostatic hypertrophy Global Market Report 2024 – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs For Erectile Dysfunction Global Market Report 2024 – By Drugs (Sildenafil Citrate, Mirodenafil , Vardenafil), By Mode of Administration (Oral, Topical, Injections), By End users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2024 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Diuretics Global Market Report 2024 – By Type (Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides & Thiazide-Like Diuretics, Aldosterone Antagonists), By Distribution (Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), By Application (Hypertension, Glaucoma, Heart Failure, Kidney Stones) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Global Market Report 2024 – By Type (Urinary Incontinence Devices, Pelvic Organ Prolapse Devices), By Urinary Incontinence Devices (Artificial Urinary Sphincters, Electrical Stimulation Devices, Urethral Slings, Catheters), By Pelvic Organ Prolapse Devices (Vaginal Mesh, Vaginal Pessary), By Incontinence Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Use) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Urinary Stone Treatment Devices And Equipment Global Market Report 2024 – By Product (Extracorporeal Shock Wave Lithotripsy Devices, Holmium Laser Devices, Intracorporeal Lithotripsy Devices, Stone Retrieval Devices, Ureteral Stents), By Stone Type (Calcium Stones, Struvite, Uric Acid, Cystine, Drug-Induced), By End User (Hospitals, Ambulatory Surgery Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bladder Cancer Drugs Global Market Report 2024 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the genito-urinary drugs market?

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities that produce genito-urinary drugs to treat genito-urinary diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases request a sample here

How will the genito-urinary drugs market drivers and restraints affect genito-urinary drugs market dynamics? What forces will shape the genito-urinary drugs industry going forward?

The genito-urinary drugs market growth is aided by aging population profile. However, some genito-urinary drugs market restraints include regulatory agencies and federal governments adopted stringent regulations request a sample here

What is the forecast market size of the genito-urinary drugs market?

The genito-urinary drugs market forecast is expected to reach $63.95 billion in 2023 at a compound annual growth rate of 4%. request a sample here

How is the genito-urinary drugs market segmented?

The global genito-urinary drugs market is segmented -
1) By Type: Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the genito-urinary drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global genito-urinary drugs market?

Top competitors in the genito-urinary drugs market are Daiichi Sankyo Company, Pfizer Inc, Bayer AG, Astellas Pharma Inc, Allergan Plc. request a sample here.

What are the key trends in the global genito-urinary drugs market?

Major trends influencing the genito-urinary drugs market include investing in development of new class drugs for treating overactive bladders (OAB) request a sample here.

What are the major opportunities in the genito-urinary drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global genito-urinary drugs market, request a sample here.

How does the genito-urinary drugs market relate to the overall economy and other similar markets?

request a sample here.